Book the Most Important Interventional Cardiology Meetings in 2018

March 10-12 | ACC 2018 – American College of Cardiology 

The first major annual meeting is the American College of Cardiology (ACC), to be held in Orlando on March 10 thru 12, in Orlando (Florida).

Date: March 10, 11, 12.

Venue: Orange County Convention Center.

City: Orlando, Florida, US.

More information 

 

May 22-25 | EuroPCR 2018

The global leading course in interventional cardiology will make the headlines next May, when the new edition of this renowned event takes place at Palais des Congrès (Paris).

Date: May 22-25, 2018

Venue: Palais des Congrès,

City: Paris, France.

More information 

 

August 25-29 | ESC Congress 2018

This event, which last year gathered over 30,000 healthcare professionals from 150 different countries, will be back in August to keep adding value to our specialty, with prestigious international guests, invaluable must-see scientific sessions and ample industry participation.  

 

Date: August Saturday 25 – Wednesday 29, 2018 (5 days),

City: Munich, Germany.

More information  

 

September 21-25 | TCT 2018

Once more, the Cardiovascular Research Foundation (CRF) prepares for the new edition of the Transcatheter Cardiovascular Therapeutics (TCT), one of the favorite meetings in the field of interventional cardiology. The event will be held in the city of San Diego (CA), USA, from September 21 thru 25, 2018.

Date: September 21 thru 25, 2018

Venue: San Diego Convention Center 

City: San Diego, CA, US.

More information 

 

November 10-14 | AHA 2018 Scientific Sessions

2018 scientific sessions will close the year with important scientific advances, new technology, and new studies in the field. The meeting will take place in Chicago, Illinois, US, from November 10 thru 14, 2018. The venue will be the Chicago Convention Center.

Date: November 10-14, 2018

Venue: Chicago Convention Center.

City: Chicago, Illinois, US.

More information 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

CHIP LATAM | Chapter 2 – Mexico: Complications Workshop

The Latin American Society of Interventional Cardiology invites the entire medical community to participate in a virtual workshop on complications organized by SOLACI’s Complex...

Fellow’s Corner 2026 – Submit Your Clinical Case

Share your experience. Learn from experts. Grow as an interventional cardiologist. The Latin American Society of Interventional Cardiology (SOLACI) is relaunching this year the Fellow’s...

Watch Again: Cardiovascular Risk Factors in Women | SOLACI Technicians Webinar

The webinar “Cardiovascular Risk Factors in Women,” held on January 27, 2026, via the Zoom platform, is now available for viewing on SOLACI’s YouTube...

Technical Training in Hemodynamics and Interventional Cardioangiology | SOLACI–CACI

The SOLACI–CACI Technical Training in Hemodynamics and Interventional Cardioangiology is an academic program designed for the initial training and professional development of non-physician healthcare...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...